Financial analysis of patients with newly diagnosed acute myelogenous leukemia on protocol or standard therapy
Antineoplastic Combined Chemotherapy Protocols
Clinical Trials as Topic
Health Care Costs
Leukemia, Myeloid, Acute
Although charges for the nonprotocol group were higher, specific factors responsible for this difference were not identified. This study emphasizes the problems inherent in assembling suitable groups of patients for comparison.